# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Malignant mesenchymal tumor

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 1826 results.
Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma
Status: Recruiting
Last Changed: Aug 19, 2019
First Received: Mar 13, 2018
Disease(s): Sarcoma
Intervention(s): nivolumab, ipilimumab
Locations: James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York, United States
Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma
Status: Recruiting
Last Changed: Dec 04, 2019
First Received: Apr 01, 2019
Disease(s): Sarcoma
Intervention(s): Blood Test - Stage 2-3 Sarcomas Preoperative RT, Blood Test - Stage 2-3 Sarcomas Postoperative RT, Blood Test - Stage 4 Sarcomas, Biopsy Sample of Tumor
Locations: Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Sarcoma Database at KFSH&RC
Status: Unknown status
Last Changed: Jan 05, 2016
First Received: Dec 13, 2011
Disease(s): Sarcoma Database
Intervention(s): Database
Locations: Kfsh & Rc, Riyadh, Saudi Arabia
Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma
Status: Recruiting
Last Changed: Feb 07, 2020
First Received: Aug 09, 2019
Disease(s): Sarcoma
Intervention(s): TIL, Interleukin-2, Fludarabine, Cyclophosphamide
Locations: Moffitt Cancer Center, Tampa, Florida, United States
Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.
Status: Not yet recruiting
Last Changed: Feb 17, 2020
First Received: Dec 20, 2018
Disease(s): Sarcoma
Intervention(s): Autologous CIK Dose level 1, Autologous CIK Dose level 2, Autologous CIK Dose level 3, Autologous CIK Dose level 4
Locations: Ospedale Infantile Regina Margherita - Unit of Paediatric Oncoematology, Torino, Italy
A Phase II Trial of Combined Hydroxychloroquine and Sirolimus in Soft Tissue Sarcoma
Status: Terminated
Last Changed: Nov 03, 2015
First Received: Apr 29, 2013
Disease(s): Sarcoma
Intervention(s): Sirolimus and hydroxychloroquine
Locations: Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
Biomarker in Tissue Samples From Patients With Ewing Sarcoma
Status: Completed
Last Changed: Jul 11, 2016
First Received: Jun 03, 2011
Disease(s): Sarcoma
Intervention(s): microarray analysis, protein analysis, immunohistochemistry staining method, laboratory biomarker analysis
A Phase II Trial Comparing Gemcitabine and Pazopanib Versus Gemcitabine and Docetaxel for Patients With Advanced Soft Tissue Sarcoma
Status: Completed
Last Changed: May 28, 2019
First Received: May 08, 2012
Disease(s): Sarcoma
Intervention(s): Gemcitabine and Pazopanib, Gemcitabine and Docetaxel
Locations: The University of Arizona Cancer Center, Tucson, Arizona, United States
University of Colorado Cancer Center, Aurora, Colorado, United States
Emory University, Atlanta, Georgia, United States
University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States
Johns Hopkins University, Baltimore, Maryland, United States
... and 4 other locations.
Burden and Medical Care of Sarcoma in Germany
Status: Active, not recruiting
Last Changed: Jan 30, 2020
First Received: May 11, 2018
Disease(s): Sarcoma
Locations: University Hospital Dresden, Dresden, Saxony, Germany
Study of Blood Samples From Patients With Ewing Sarcoma and Their Relatives
Status: Unknown status
Last Changed: Aug 26, 2013
First Received: Sep 28, 2010
Disease(s): Sarcoma
Intervention(s): genome-wide association study
Locations: Institut Curie Hopital, Paris, France